Didanosine reduces atevirdine absorption in subjects with human immunodeficiency virus infections.

Morse, G D

Didanosine reduces atevirdine absorption in subjects with human immunodeficiency virus infections. [electronic resource] - Antimicrobial agents and chemotherapy Mar 1996 - 767-71 p. digital

Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

0066-4804

10.1128/AAC.40.3.767 doi


Adolescent
Adult
Antiviral Agents--pharmacokinetics
Cross-Over Studies
Didanosine--pharmacokinetics
Drug Interactions
Female
HIV Infections--metabolism
HIV-1
Half-Life
Humans
Intestinal Absorption--drug effects
Male
Middle Aged
Piperazines--pharmacokinetics